Claret Asset Management Corp Has $234,000 Stock Position in Doximity, Inc. $DOCS

Claret Asset Management Corp lessened its holdings in Doximity, Inc. (NASDAQ:DOCS) by 42.5% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,807 shares of the company’s stock after selling 2,811 shares during the quarter. Claret Asset Management Corp’s holdings in Doximity were worth $234,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hantz Financial Services Inc. lifted its position in shares of Doximity by 148.9% during the 2nd quarter. Hantz Financial Services Inc. now owns 453 shares of the company’s stock worth $28,000 after buying an additional 271 shares during the last quarter. National Bank of Canada FI bought a new position in shares of Doximity in the first quarter worth about $33,000. Brooklyn Investment Group boosted its stake in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company’s stock valued at $43,000 after purchasing an additional 309 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Doximity by 176.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 781 shares of the company’s stock valued at $46,000 after purchasing an additional 498 shares during the last quarter. Finally, Cullen Frost Bankers Inc. increased its position in Doximity by 29.7% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,427 shares of the company’s stock worth $88,000 after purchasing an additional 327 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Wall Street Analyst Weigh In

DOCS has been the topic of a number of research analyst reports. Robert W. Baird raised their target price on shares of Doximity from $75.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, September 11th. KeyCorp raised their price objective on Doximity from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Needham & Company LLC upped their target price on Doximity from $67.00 to $75.00 and gave the stock a “buy” rating in a report on Friday, August 8th. Raymond James Financial upgraded Doximity from an “outperform” rating to a “strong-buy” rating and dropped their target price for the company from $75.00 to $65.00 in a research report on Friday, November 21st. Finally, Evercore ISI reduced their price target on Doximity from $81.00 to $70.00 and set an “outperform” rating on the stock in a report on Friday, November 7th. Two analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $68.22.

Doximity Trading Down 0.8%

Shares of DOCS opened at $51.04 on Tuesday. The company has a market capitalization of $9.61 billion, a PE ratio of 51.04, a PEG ratio of 4.10 and a beta of 1.36. Doximity, Inc. has a 12 month low of $46.04 and a 12 month high of $85.21. The stock’s 50-day moving average price is $62.75 and its two-hundred day moving average price is $61.80.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the firm posted $0.30 EPS. Doximity’s quarterly revenue was up 23.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Equities research analysts predict that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Activity at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction that occurred on Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the sale, the director owned 3,221 shares of the company’s stock, valued at approximately $241,575. This represents a 86.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $66.44, for a total transaction of $132,880.00. Following the completion of the transaction, the director owned 19,839 shares in the company, valued at $1,318,103.16. This trade represents a 9.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 32,000 shares of company stock worth $2,339,580 over the last ninety days. Insiders own 31.30% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.